RNS Number : 0167D
Microgen PLC
23 January 2015
 



23 January 2015

 

Microgen plc (the "Company")

 

Notifiable Interests

 

The Company received the following notice on 22 January 2015 in compliance with the Disclosure and Transparency Rules from Aberforth Partners LLP:

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:

Microgen PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify)


3. Full name of person(s) subject to the
notification obligation:

Aberforth Partners LLP

4. Full name of shareholder(s)
 (if different from 3.):

Shareholder:                                                             Shares:                                                    

1.  Aberforth Smaller Companies Trust plc               7,548,531

2.  Aberforth UK Small Companies Fund                 1,196,872

3.  Aberforth Geared Income Trust plc                     1,766,000

 

All shares are registered in the name of Nortrust Nominees Ltd A/c Aberfrth

5. Date of the transaction and date on
which the threshold is crossed or
reached:

21/01/2015

6. Date on which issuer notified:

22/01/2015

7. Threshold(s) that is/are crossed or
reached:

14%


 

8. Notified details:

A: Voting rights attached to shares

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary

9,999,708

9,999,708

10,511,403

N/A

10,511,403

N/A

14.09

GB0005869531


B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date xiii

Exercise/
Conversion Period xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

N/A

N/A

N/A

N/A

N/A


C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

N/A

N/A

N/A

N/A

 

N/A

Nominal

Delta

N/A

N/A


Total (A+B+C)

Number of voting rights

Percentage of voting rights

10,511,403

14.09


 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi

Held by Aberforth Partners LLP

 


Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease
to hold:

N/A

12. Date on which proxy holder will cease to hold
voting rights:

N/A



13. Additional information:

In addition, Aberforth Partners LLP is interested in a further 5,516,411 shares although it does not have access to the voting rights of these shares.  Aberforth Partners LLP is, therefore, interested in a total of 16,027,814 shares of Microgen plc.  This interest arises as a result of the discretionary investment management powers that Aberforth Partners LLP can exercise over the funds of its clients.  Aberforth Partners LLP is not the beneficial owner of these shares.

14. Contact name:

Pauline Robson, Aberforth Partners LLP

15. Contact telephone number:

0131 220 0733

 

If you require further information please contact:

Anjum O'Neill, Company Secretary, Microgen plc                                       Tel: 020 7496 8100

www.microgen.com

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLSELFDDFISEFF